Definitive Contract 75A50125C00005
Award Date
7/25/25
Potential Completion Date
2/28/27
Potential Value
$742K
Awardee
Flugen Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $35,019,405.00 firm fixed-price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a foreign-owned, for-profit biotechnology company that specializes in pandemic preparedness and response. The purpose of the contract is to procure an influenza A(H2Nx) virus vaccine candidate(s) and conduct related clinical trials. This order is part of a larger $13.4 billion...
This federal contract award, identified as 75A50118P00012, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $42,247 firm fixed-price purchase order was awarded to Seqirus Inc., a foreign-owned, for-profit manufacturer of medical countermeasures, vaccines, and related products. The contract has no set-aside designation and was issued under Seqirus' $13.4 billion Indefinite...
This is a $224,981.00 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Epitogenesis Inc., a minority-owned, economically disadvantaged women-owned small business. The contract is for the development of "A NUTRITIVE VACCINE ADJUVANT AGAINST INFLUENZA" and has a period of performance ending on September 14, 2015. The contract was set aside for small businesses.
This is a federal contract award to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the delivery of influenza virus vaccines. The contract has a ceiling value of $307,666.00 and an ultimate completion date of April 26, 2025. It was awarded on April 27, 2020 by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price pricing type. Seqirus USA Inc. is a global...
This federal contract award was made by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $18,890,210.47 fixed-price delivery order is for the acquisition of medical countermeasures for pandemic influenza preparedness and response. The contract is a task order under a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded by HHS...
This federal contract award is for $487,277.80 and was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of global biotechnology company CSL Seqirus. The contract is a delivery order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC), a $13.4 billion vehicle that serves as the primary mechanism for Seqirus' federal contracting activities...
This $642,000.00 firm-fixed-price delivery order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a multi-year vehicle managed by ASPR. The contract supports the delivery of influenza vaccines, which Seqirus specializes in manufacturing and supplying to various...
The U.S. Department of Defense's Medical Supply Chain awarded a $3,102,020.00 firm fixed-price delivery order contract to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 13, 2023. This delivery order is part of Seqirus's existing Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency and Centers for Disease Control and Prevention, which allow federal agencies...
This is a $2,500,000.00 firm fixed price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to MedImmune LLC. The contract is for the production of a Coronavirus Genomics Manufacturing and Production (CGMP) influenza vaccine clinical lot under the Pandemic Influenza Preparedness and Response 2012-2016 contract vehicle. There is no set-aside designation for this award. The ultimate...
This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC for $1,800,000.00. The contract is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle, which is used by ASPR to procure products and services related to pandemic preparedness. The contract has an ultimate completion date of October 31, 2018 and does...